Share price
$1.03
As of Apr 29, 2026
ABVC | NASDAQ
Abvc Biopharma, Inc. (ABVC) | runway 1.4 months | financing risk high | market cap $27.4M. Daily snapshot of financials, capital pressure, and recent develop...
Share price
$1.03
As of Apr 29, 2026
Market cap
$27.4M
Snapshot valuation
30D volume
117,922 shares
Rolling average daily volume
Runway
1.4 months
Estimated from precomputed burn and cash
Financing risk
N/A
The company screens as likely to return to the capital markets soon.
Runway: 1.4 months based on estimated burn.
Financing signal: The company screens as likely to return to the capital markets soon.
Latest development: ABVC BIOPHARMA, INC. 8-K 2026-03-27.
8-K filed on 2026-03-27.
10-K filed on 2026-03-03.
8-K filed on 2026-03-03.
424B4 filing submitted on 2025-11-14.
8-K filed on 2025-11-03.
Low cash runway companies
Companies screening with the shortest estimated runway based on precomputed burn and cash snapshots.
High burn rate companies
Companies with the highest estimated trailing cash burn across the monitored issuer set.
Recent financing disclosures
Companies with recent financing activity, capital raises, or post-balance-sheet funding events.
Pre-market filings
Companies with recent filings or disclosures posted before the market open.
ABVC BIOPHARMA, INC. 8-K 2026-03-27
8-K filed on 2026-03-27.
ABVC BIOPHARMA, INC. 8-K 2026-03-03
8-K filed on 2026-03-03.
ABVC BIOPHARMA, INC. 10-K 2026-03-03
10-K filed on 2026-03-03.
ABVC BIOPHARMA, INC. 424B4 2025-11-14
424B4 filing submitted on 2025-11-14.
Premium analysis
Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.